Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Longboard Pharmaceuticals, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20
   10-K8-K10-K8-K10-K
Revenues  44.834.60.019.80.0
            Revenue growth   75.2%   
Cost of goods sold  0.044.80.027.80.0
Gross profit  44.8-10.20.0-8.10.0
            Gross margin  100.0%-29.3% -40.8% 
Selling, general and administrative   [+]10.210.28.18.19.8
Research and development  34.6 19.8 4.6
Other operating expenses  44.824.5 11.7 
EBITDA   [+]-44.8 -27.8  
            EBITDA margin  -100.0%-129.3% -140.8% 
Depreciation and amortization  0.0 0.0  
EBIT   [+]-44.8-44.8-27.8-27.8-14.4
            EBIT margin  -100.0%-129.3% -140.8% 
Interest income  0.80.80.10.1 
Other income (expense), net  0.00.00.00.0 
Pre-tax income  -43.9-43.9-27.8-27.8-14.4
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income  -43.9-43.9-27.8-27.8-14.4
            Net margin  -98.1%-126.9% -140.6% 
   
Basic EPS   [+]($2.56)($2.56)($1.93)($1.93)($3.78)
Diluted EPS   [+]($2.56)($2.56)($1.93)($1.93)($3.78)
   
Shares outstanding (basic)   [+]17.217.214.414.43.8
Shares outstanding (diluted)   [+]17.217.214.414.43.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy